Bacterial macromolecule synthesis (MMS)

Bacterial macromolecule synthesis refers to the collective biological pathways responsible for the production of essential cellular components, including DNA, RNA, proteins, and the cell wall. These processes are fundamental to bacterial growth, replication, and survival, making them the primary focus of most antibiotic development. The machinery involved includes highly conserved enzymes and complexes such as DNA gyrase, RNA polymerase, the 70S ribosome, and penicillin-binding proteins. Because these bacterial systems often differ significantly from their eukaryotic counterparts, they provide a basis for selective toxicity in treating bacterial infections. Drugs that disrupt these pathways can either stop bacterial growth (bacteriostatic) or directly kill the bacteria (bactericidal). However, the term is considered a broad category or pathway rather than a single molecular target, as it encompasses multiple distinct enzymatic reactions and structural assemblies.

Other names

Bacterial macromolecular biosynthesisBacterial polymer synthesisBacterial replication, transcription, and translation pathways

Drugs targeting bacterial macromolecule synthesis act by inhibiting the enzymatic machinery responsible for producing essential polymers, such as DNA, RNA, proteins, and peptidoglycan, thereby causing bacteriostatic or bactericidal effects.